Xenetic Biosciences, Inc. announced that Ari Nagler resigned as the company's former sole officer and director. The company appointed new directors and executive officers as: Brian Richards as Director; M Scott Maguire as Chief Executive Officer, Director; Colin William Hill as Chief Financial Officer, Director; Firdaus Jal Dastoor as Director; and Artur Isaev as Director.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.07 USD | -1.93% |
|
-8.74% | +17.97% |
05-22 | Xenetic Biosciences, Inc. Announces Management Resignations | CI |
05-22 | Xenetic Biosciences, Inc. Announces Chief Executive Officer Changes | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.97% | 6.27M | |
+15.20% | 121B | |
+19.67% | 113B | |
+18.95% | 26.02B | |
-23.86% | 19.39B | |
-19.03% | 15.91B | |
-20.90% | 15.09B | |
-46.14% | 15.06B | |
+63.85% | 14.93B | |
+4.49% | 13.85B |
- Stock Market
- Equities
- XBIO Stock
- News Xenetic Biosciences, Inc.
- Xenetic Biosciences, Inc. Announces Management Changes